Best of ASCO Metastatic Non-Small Cell Lung Cancer
Transforming Treatment in Ovarian Cancer
BR.21 Study Design *2:1 Randomization R Stratified by: Centre PS, 0/1 vs 2/3 Response to prior Rx (CR/PR:SD:PD) Prior regimens, (1 vs 2) Prior platinum,
Bevacizumab in MBC 1 Breast Cancer Take home message Sabino De Placido.
Nimotuzumab and radiotherapy in children and adolescents with brain stem glioma: Preliminary results from a Phase II study. T. Crombet 1, R. Cabanas 2,
New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong.
Research and Development in Pulmonary Fibrosis: The Future is Bright Glenn D. Rosen, M D Associate Professor of Medicine Interim Co-Chief and Program Director.
Vervolg CASUS. september 2009 -inmiddels 6 kuren R-CVP ondergaan -restadiering: PR EN NU?
Challenges and Success: Treatment of Metastatic Breast Cancer 2012 Hope S. Rugo University of California San Francisco Helen Diller Family Comprehensive.
G. Cartenì Direttore U.O.S.C. di Oncologia Medica A.O.R.N. A. Cardarelli Napoli Roma, 22 febbraio 2013 Highlights in the management of renal cell carcinoma.
Raccomandazioni di AIOM e SIAPEC-IAP Nicola Normanno ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI FONDAZIONE G. Pascale – NAPOLI SC Biologia Cellulare.
(PowerPoint)
